Drug Trial Radar · NCT04947553
A Study to Assess the Long-term Safety and Efficacy of AXS-05 in Subjects With Alzheimer's Disease Agitation
Last checked: Nov 19, 2026Latest source record: Dec 8, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
456
Actual
Start
Jun 17, 2021
Primary completion
Dec 3, 2024
Study completion Dec 21, 2024
Sponsor
- Lead sponsor
- Axsome Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jul 1, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 65 years, up to 90 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate the long-term safety and efficacy of AXS-05 in subjects with Alzheimer's disease (AD) agitation.
Conditions
- Agitation in Patients With Dementia of the Alzheimer's Type
- Alzheimer Disease
- Agitation, Psychomotor
Interventions
AXS-05 (dextromethorphan-bupropion)Drug
AXS-05 tablets, taken twice daily
PlaceboDrug
Placebo tablets, taken twice daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Long-term SafetyTime frame: up to 76 weeks
- Time to relapse of agitation symptomsTime frame: up to 24 weeks
Locations
47 sites in 3 countries. Site status is shown where the registry gives one.
Clinical Research Site
Peoria, Arizona
Clinical Research Site
Tempe, Arizona
Clinical Research Site
Long Beach, California
Clinical Research Site
Santa Ana, California
Clinical Research Site
Temecula, California
Clinical Research Site
Walnut Creek, California
Clinical Research Site
Bonita Springs, Florida
Clinical Research Site
Brandon, Florida
Clinical Research Site
Coral Springs, Florida
Clinical Research Site
Greenacres City, Florida
Clinical Research Site
Hialeah, Florida
Clinical Research Site
Hollywood, Florida
Clinical Research Site
Kissimmee, Florida
Clinical Research Site
Lake City, Florida
Clinical Research Site
Miami, Florida
Clinical Research Site
Miami, Florida
Clinical Research Site
Miami, Florida
Clinical Research Site
Miami, Florida
Clinical Research Site
Miami, Florida
Clinical Research Site
Miami, Florida
Clinical Research Site
Miami, Florida
Clinical Research Site
Miami Gardens, Florida
Clinical Research Site
Miami Lakes, Florida
Clinical Research Site
Orlando, Florida
Clinical Research Site
Pembroke Pines, Florida
Clinical Research Site
Tampa, Florida
Clinical Research Site
Tampa, Florida
Clinical Research Site
Trinity, Florida
Clinical Research Site
Columbus, Georgia
Clinical Research Site
Wichita, Kansas
Clinical Research Site
Braintree, Massachusetts
Clinical Research Site
Flint, Michigan
Clinical Research Site
Rochester Hills, Michigan
Clinical Research Site
Chesterfield, Missouri
Clinical Research Site
Toms River, New Jersey
Clinical Research Site
Brooklyn, New York
Clinical Research Site
New Windsor, New York
Clinical Research Site
Staten Island, New York
Clinical Research Site
Charlotte, North Carolina
Clinical Research Site
Hickory, North Carolina
Showing 40 of 47 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.